2026 Week 6 Fantasy Football: Eagles Won't Place Jalen Hurts on IR Despite Blood Clot

According to ProFootballTalk (NBC Sports), the Philadelphia Eagles have no plans to place quarterback Jalen Hurts on injured reserve, despite him being out indefinitely with a blood clot in his leg. The news comes via an ESPN report from Adam Schefter and Ian Rapoport, which also notes that the Eagles haven't even discussed the IR possibility internally.

The wrinkle: Hurts is being treated with blood thinners and cannot play while on them. ProFootballTalk points out that Philadelphia plays four games over the next 22 days — against the Panthers, Cowboys, and then at the Commanders and Giants — before their bye. That's effectively a five-week window where Hurts is a near-zero chance to suit up, making the decision to avoid IR puzzling. Doctors not involved in his treatment, cited by ESPN, suggest he could miss up to six weeks.

There's an additional roster squeeze worth noting. The Eagles are operating on a 51-man active roster because retired right tackle Lane Johnson remains on the books for 2026 cap reasons. Skipping IR costs the team a roster spot on top of that — a real operational cost with no clear upside explained so far.

Jalen Hurts

Hurts is effectively a zero for fantasy purposes right now — he can't play while on blood thinners, and the Eagles have given no timeline for when that changes. The IR news matters mainly for roster management: because Philadelphia isn't placing him on IR, fantasy managers in leagues with IR slots cannot stash Hurts there to free up an active roster spot. Check your league's rules, but if IR eligibility requires an official IR designation, Hurts almost certainly won't qualify under the current plan. In dynasty formats, the six-week ceiling on his absence (per the unaffiliated doctors cited by ESPN) is the key number to watch, but that's not a confirmed timeline from the team or his treating physicians. Treat him as week-to-week at best and plan your lineup accordingly.